Kristen Belmonte Slaoui Biography
Kristen Belmonte Slaoui is the Chief Corporate Development Officer at Galderma. Slaoui is also known as Moncef Slaoui’s wife. Moncef Slaoui is an American researcher who previously served as the head of GlaxoSmithKline’s vaccines department.
Kristen Belmonte Slaoui Age and Birthday
Belmonte Slaoui was born in July 1970. She is 53 years of age as of 2023. Her husband Moncef Slaoui was born on July 22, 1959, making him 64 years as of the time of this writing.
Kristen Belmonte Slaoui Height and Weight
Belmonte Slaoui is of average stature. She stands at 5 feet 7 inches and is of average weight.
Kristen Belmonte Slaoui Education
Belmonte Slaoui attended Gettysburg College, a private liberal arts college in Gettysburg, Pennsylvania, where she graduated with a Bachelor’s degree in Biology and Classical Studies.
Kristen then furthered her studies at Johns Hopkins Bloomberg School of Public Health in Maryland where she earned a Ph. D in Physiology.
Kristen Slaoui Husband and Son
Belmonte Slaoui is married to Moncef Mohamed Slaoui, a Moroccan-born Belgian-American researcher and former head of GlaxoSmithKline’s vaccines department. The couple has a son named Ryan.
Kristen Belmonte Slaoui Net Worth
According to her LinkedIn, Kristen has executed more than $30 billion worth of deals and acquisitions since joining GSK’s Business Development teams in 2006. We estimate Kristen Belmonte Slaoui’s net worth at $1 million.
Kristen Belmonte Slaoui GSK
Belmonte Slaoui spent 20 years with the British multinational pharmaceutical company GSK. She started out in the research labs, where her work in pulmonary disease resulted in the development of the long-acting muscarinic receptor antagonist in the approved medicines Anoro™ Ellipta™, Incruse™ Ellipta™, and Trelegy™ Ellipta™.
Kristen Belmonte Slaoui Galderma
Galderma S.A. is a Swiss pharmaceutical company specializing in dermatological treatments and skincare products, Kristen is the Chief Corporate Development Officer at Galderma a position she secured in September 2020.